Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant

Leukemia and Lymphoma

Volumn 45, Issue 11, 2004, Pages 2261-2267

  Jagasia, Madan ^a   Morgan, David ^a   Goodman, Stacey ^b   Hamilton, Katherine ^a   Kinney, Marsha ^c   Shyr, Yu ^a   Stein, Richard ^a   Zic, John ^a   Greer, John ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

ALCL; PTCL; Stem cell transplant

Indexed keywords

ASPARAGINASE; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PACLITAXEL; PHOSPHOTRANSFERASE; PREDNISONE; TOPOTECAN; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; MALE; OUTCOMES RESEARCH; PERIPHERAL T CELL LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SKIN LYMPHOMA; STATISTICAL ANALYSIS; STEM CELL TRANSPLANTATION; SURVIVAL TIME; WORLD HEALTH ORGANIZATION;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, KI-1; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN-TYROSINE KINASES; RECURRENCE; STEM CELL TRANSPLANTATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 8644231731     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190412331272749     Document Type: Article

References (30)

1. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der, L., Bron, D., et al. (1995) "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", New England Journal of Medicine, 333, 1540-1545.
2. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood, 84, 1361-1392.
3. Cheng, A.L., Chen, Y.C., Wang, C.H., Su, I.J., Hsieh, H.C., Chang, J.Y., et al. (1989) "Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades - should peripheral T-cell Lymphoma be considered separately?", Journal of Clinical Oncology, 7, 725-731.
4. Coiffier, B., Brousse, N., Peuchmaur, M., Berger, F., Gisselbrecht, C., Bryon, P.A. and Diebold, J. The GELA (Groupe d'Etude des Lymphomes Agressives) (1990) "Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen", Annals of Oncology, 1, 45-50.
5. Lippman, S.M., Miller, T.P., Spier, C.M., Slymen, D.J. and Grogan, T.M. (1988) "The prognostic significance of the immuno-type in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype", Blood, 72, 436-441.
6. Gisselbrecht, C., Lepage, E., Molina, T., Quesnel, B., Fillet, G., Lederlin, P., et al. (2002) "Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma", Journal of Clinical Oncology, 20, 2472-2479.
7. Rodriguez, J., Munsell, M., Yazji, S., Hagemeister, B., Younes, A., Andersson, B., et al. (2001) "Impact of high-dose chemotherapy on peripheral T-cell lymphomas", Journal of Clinical Oncology, 19, 3766-3770.
8. World Health Organization Classification of Tumors (2001) Pathology and Genetics. Tumors of Hematopoietic and Lymphoid Tissues.
9. Stein, H. (1993) "Ki-1-anaplastic large cell lymphoma: is it a discrete entity?", Leukemia and Lymphoma, 10, 81-84.
10. Kaneko, Y., Frizzera, G., Edamura, S., Maseki, N., Sakurai, M., Komada, Y., et al. (1989) "A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T- cell lymphoma mimicking malignant histiocytosis", Blood, 73, 806-813.
11. Le Beau, M.M., Bitter, M.A., Larson, R.A., Doane, L.A., Ellis, E.D., Franklin, W.A., et al. (1989) "The t(2;5)(p23; q35): a recurring chromosomal abnormality in Ki-1- positive anaplastic large cell lymphoma", Leukemia, 3, 866-870.
12. Morris, S.W., Kirstein, M.N., Valentine, M.B., Dittmer, K., Shapiro, D.N., Look, A.T. and Saltman, D.L. (1994) "Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma", Science, 263, 1281-1284.
13. Morris, S.W., Naeve, C., Mathew, P., James, P.L., Kirstein, M.N., Cui, X. and Witte, D.P. (1997) "ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)", Oncogene, 14, 2175-2188.
14. Pulford, K., Lamant, L., Morris, S.W., Butler, L.H., Wood, K.M., Stroud, D., et al. (1997) "Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1", Blood 89, 1394-1404.
15. Stein, H., Foss, H.D., Durkop, H., Marfioti, T., Delsol, G., Pulford, K., et al. (2000) "CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features", Blood, 96, 3681-3695.
16. Falini, B., Pileri, S., Zinzani, P.L., Carbone, A., Zagonel, V., Wolf-Peters, C., et al. (1999) "ALK + lymphoma: clinico-pathological findings and outcome", Blood, 93, 2697-2706.
17. Gascoyne, R.D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B.F., Greiner, T.C., et al. (1999) "Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma", Blood, 93, 3913-3921.
18. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. and Tubiana, M. (1971) "Report of the Committee on Hodgkin's Disease Staging Classification", Cancer Research, 31, 1860-1861.
19. Stein, R.S., Greer, J.P., Goodman, S., Brandt, S.J., Morgan, D.S., Macon, W.R., et al. (2000) "Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma", Bone Marrow Transplantation, 25 257-262.
20. Beylot-Barry, M., Lamant, L., Vergier, B., De Muret, A., Fraitag, S., Delord, B., et al. (1996) "Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis", American Journal of Pathology 149, 483-492.
21. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", New England Journal of Medicine, 329, 987-994.
22. Gisselbrecht, C., Gaulard, P., Lepage, E., Coiffier, B., Briere, J., Haioun, C., et al. (1998) "Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)", Blood, 92, 76-82.
23. Falini, B. (2001) "Anaplastic large cell lymphoma: pathological, molecular and clinical features", British Journal of Haematology, 114, 741-760.
24. Fanin, R., Ruiz de Elvira, M.C., Sperotto, A., Baccarani, M. and Goldstone, A. (1999) "Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and pediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)", Bone Marrow Transplantation, 23 437-442.
25. Haioun, C., Lepage, E., Gisselbrecht, C., Salles, G., Ciffier, B., Brice, P., et al. (2000) "Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol - a groupe d'Etude des lymphomes de l'Adulte study", Journal of Clinical Oncology, 18 3025-3030.
26. Mounier, N., Simon, D., Haioun, C., Gaulard, P. and Gisselbrecht, C. (2002) "Impact of high-dose chemotherapy on peripheral T-cell lymphomas", Journal of Clinical Oncology, 20, 1426-1427.
27. Blystad, A.K., Enblad, G., Kvaloy, S., Berglund, A.A., Delabie, J., Holte, H., et al. (2001) "High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas", Bone Marrow Transplantation, 27, 711-716.
28. Song, K.W., Mollee, P., Keating, A. and Crump, M. (2002) "Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype", British Journal of Hematology, 120, 978-985.
29. Vose, J.M., Peterson, C., Bierman, P.J., Weisenburger, D.D., Linder, J., Harrington, D., et al. (1990) "Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas", Blood, 76, 424-431.
30. Blay, J., Gomez, F., Sebban, C., Bachelot, T., Biron, P., Guglielmi, C., et al. (1998) "The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group", Blood, 92, 3562-3568.